Professor Houman Ashrafian
Professor Houman Ashrafian was appointed in a total of 8 companies and resigned from 6 of these appointments.
Roles
Director • Non-designated LLP Member
Country Of Residence
England
Nationality
British
Date of Birth
February 1975
Occupations
Venture Partner / Academic Clinician • Venture Partner / Professor • Unreported • Clinician
Active
0
Resigned
6
Dissolved
2
Other
0
Total
8
Companies
| Company | Timeline | Status | |
| Mestag Therapeutics Ltd Director • Director | 17 Apr 2020←3 Years→29 Jun 2023 | Active | |
| Cellinta Ltd Director • Director | 10 Mar 2020←3 Years→7 Aug 2023 | Active | |
| Cybele Therapeutics Ltd Director • Director | 11 Dec 2019←2 Years 5 Months→31 May 2022 | Dissolved | |
| Karus Therapeutics Limited Director • Venture Partner / Academic Clinician | 24 Jan 2019←4 Years→12 Jul 2023 | Dissolved | |
| Trex Bio Limited Director • Venture Partner / Professor | 30 Jan 2018←4 Years→21 Apr 2022 | Liquidation | |
| SV Health Managers LLP Non-designated LLP Member • Unreported | 12 Jan 2018←5 Years→31 Aug 2023 | Active | |
| Enara Bio Limited Director • Clinician | 8 Nov 2016←6 Years→14 Jun 2023 | Active | |
SV Health Investors LLP Non-designated LLP Member • Unreported | 3 Oct 2016←2 Years 12 Months→1 Oct 2019 | Dissolved | |
Mutual People
- Dame Catherine Elizabeth BinghamMestag Therapeutics Ltd, SV Health Managers LLP, Cybele Therapeutics Ltd, and 3 more are mutual companies.
- Mr James Allister John CostineSV Health Investors LLP, Mestag Therapeutics Ltd, SV Health Managers LLP, and 2 more are mutual companies.
- Mr Graham John BoulnoisSV Health Investors LLP and Karus Therapeutics Limited are mutual companies.
- Dr Andrew William SmithSV Health Managers LLP and SV Health Investors LLP are mutual companies.
- Mr Nicholas Robert ColemanSV Health Managers LLP and SV Health Investors LLP are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
